When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GILD - Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching Drug Development
Gilead Sciences Inc.
Gilead Sciences (GILD) announced a partnership with Nurix Therapeutics to develop potential drugs to treat cancer and other diseases. This is a good deal for the company, because it gets another partnership on board as it struggles to establish a solid pipeline. Gilead has been able to acquire/develop deals for NASH in the past few years. It seems that the company is taking a different route this time. The only downside is that yet again this is a partnership starting from the research phase of clinical development. The good news is that it